NEW BLOOD TEST CAN PREDICT FUTURE BREAST CANCER
According to the World
Health Organization, breast cancer is one of the most common cancer in women
both in the developed and less developed world, and in the long term the
scientists hope that the new method will lead to better prevention and early
treatment of the disease.
The method is better
than mammography, which can only be used when the disease has already occurred.
It is not perfect, but it is truly amazing that we can predict breast cancer
years into the future," said Rasmus Bro, a professor of chemometrics in
the Department of Food Science at University of Copenhagen. He stressed the
method has been tested and validated only for a single population (cohort) and
needs to be validated more widely before it can be used practically.
A new way of detecting
diseases
Nevertheless, the
method could create a paradigm shift in early diagnosis of breast cancer as
well as other diseases.
"The potential is
that we can detect a disease like breast cancer much earlier than today. This
is important as it is easier to treat if you discover it early. In the long
term, it will probably also be possible to use similar models to predict other
diseases," said Lars Ove Dragsted, a professor of biomedicine in the
Department of Nutrition, Exercise and Sports.
The method has been
developed in cooperation with the Danish Cancer Society and the study was
recently published in Metabolomics.
Food science showed
the way
The researchers'
approach to developing the method was adopted from food science, where it is
used for control of complex industrial processes. Basically, it involves
handling and analysing huge amounts of biological data in a holistic and
explorative way. The researchers analysed all compounds a blood sample contains
instead of -- as is often done in health and medical science -- examining what
a single biomarker means in relation to a specific disease.
"When a huge
amount of relevant measurements from many individuals is used to assess health
risks -- here breast cancer -- it creates very high quality information. The
more measurements our analyses contain, the better the model handles complex
problems," continued Professor Rasmus Bro.
The model does not
reveal anything about the importance of the single biomarkers in relation to
breast cancer, but it does reveal the importance of a set of biomarkers and
their interactions.
"No single part
of the pattern is actually necessary nor sufficient. It is the whole pattern
that predicts the cancer," said Professor Dragsted.
A metabolic blood
profile describes the amounts of all compounds (metabolites) in our blood. The
scientists measured metabolic blood profiles for this project. When you are in
a pre-cancer state, the pattern for how certain metabolites are processed
apparently changes.
While a mammography
can detect newly developed breast cancer with a sensitivity of 75 per cent, the
new metabolic blood profile is able to predict the likelihood of a woman
developing breast cancer within the next two to five years with a sensitivity
of 80 per cent.
Based on population
study
The research is based
on a population study of 57,000 people followed by the Danish Cancer Society
over 20 years. The participants were first examined in 1994-96, during which
time their weight and other measurements were recorded and they answered a
questionnaire. They also provided a blood sample that was stored in liquid
nitrogen.
The scientists used
the 20-year-old blood samples and other available data from 400 women who were
healthy when they were first examined but who were diagnosed with breast cancer
two to seven years after providing the first sample, and from 400 women who did
not develop breast cancer.
The method was also
used to test a different dataset of women examined in 1997. Predictions based
on the new set of data matched the first dataset, which indicates the validity
of the model.
Comments
Post a Comment